Medical Under The Microscope

Having spent the majority of his career in academia, it is unsurprising that Juan Ochoa has brought scientific rigour and analysis to his role as Chief Medical Officer at Nestle Health Science. He focuses on commercialising concepts that originate in the laboratory by developing value propositions based on clinical and real-world evidence.The former trauma surgeon tells eyeforpharma that the value of a company and the solutions that they bring are ultimately determined by their capacityto solve unmet needs for the end consumer. According to Ochoa, there are several targets in healthcare – the patient, the physician, and the payer. “The patient is always at the centre,” he says. “As a company, you need to keep that focus to succeed.”Value is the word on everyone ’s lips, but Ochoa is dubious when it comes to its penetration into health care practices. “I It is essential that companies embrace value; they have to talk the talk and walk the walk.”Ochoa has devised a template for an “evidence development process”, which he says is the scientific way to succeed in creating a high value product that provides a solution to an unmet need. The business case must consider three value perspectives – the foundational value, the clinical value, and the health care value (in that p articular order). The first two are essential, he notes; without these, the real-world evidence that demonstrates health care value cannot be created.“The first question is always “what...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news